Daily Archives: November 11, 2019
Mon November 11 – 10 Stories of The Day!
11 Nov, 2019 | 11:40h | UTC
1 – Development of Risk Prediction Equations for Incident Chronic Kidney Disease – JAMA (free for a limited period)
See Calculator: Risk of Developing Reduced Kidney Function (free tool)
Editorial: Predicting Risk of Kidney Disease: Is Risk-Based Kidney Care on the Horizon? – JAMA (free for a limited period)
Commentaries: New Tool Predicts Five-Year Risk of Chronic Kidney Disease With High Accuracy – Johns Hopkins Bloomberg School of Public Health (free) AND Researchers Develop Tool to Identify Those at Risk of Future CKD – AJMC (free)
#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019
2 – Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials – JAMA (free for a limited period)
Commentary: Supplements don’t preserve kidney health in Type 2 diabetes – University of Washington School of Medicine (free)
#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019
3 – Association of Baclofen with Encephalopathy in Patients With Chronic Kidney Disease – JAMA (free for a limited period)
Commentary: Common muscle relaxant causes severe confusion in patients with kidney disease – University of Western Ontario (free)
#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019
4 – A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Novel Drug Eases Uremic Pruritus – Renal & Urology News (free)
#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019
#KidneyWk – Just presented at the American Society of Nephrology Kidney Week 2019
6 – CDC Reports: Risk Factors for E-Cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products — Illinois, July–October 2019 (free) AND Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019 (free)
Commentaries: In a breakthrough, health officials identify possible culprit behind vaping illnesses: vitamin E acetate – STAT (free) AND Vaping Illnesses Are Linked to Vitamin E Acetate, C.D.C. Says – The New York Times (10 articles per month are free) AND CDC Finds Possible Culprit In Outbreak Of Vaping-Related Lung Injuries – NPR (free)
Related: Viewpoint: Vaping—Seeking Clarity in a Time of Uncertainty (free) AND “EVALI” (e-cigarette, or vaping, product use-associated lung injury): CDC Updates Guidance and Creates New Name (free)
Related Guidelines: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease (free guideline and resources) AND Cardiovascular disease: risk assessment and reduction, including lipid modification – National Institute for Health and Care Excellence (free) AND Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update – Canadian Medical Association Journal (free)
8 – #181 The Multimorbidity Games with Josh Uy MD – The Curbsiders Internal Medicine Podcast (free audio)
See also: Episode List
Related: Multimorbidity: clinical assessment and management – NICE Guideline (free) AND Multimorbidity in Older Adults with Cardiovascular Disease – American College of Cardiology, Latest in Cardiology (free) AND Effectiveness of interventions for managing multiple high-burden chronic diseases in older adults: a systematic review and meta-analysis – Canadian Medical Association Journal (free) AND Multimorbidity: a priority for global health research – The Academy of Medical Sciences (free)
9 – Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk: Results of the PARAFLUO Multicenter Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Invited Commentary: New Technique to Reduce the Risk For Hypocalcemia in Thyroid Surgery (free for a limited period)
Commentary: FDA Updates Warning on Biotin Interfering with Lab Results – NEJM Journal Watch (free)
“…the FDA is particularly concerned about biotin interference causing a falsely low result for troponin, a clinically important biomarker to aid in the diagnosis of heart attacks, which may lead to a missed diagnosis and potentially serious clinical implications. The FDA continues to receive adverse events reports indicating biotin interference caused falsely low troponin results.”